Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Autonomic dysfunction in multiple sclerosis.
Functional relevance for multiple sclerosis-associated genetic variants.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
Enabling Precision Medicine With Digital Case Classification at the Point-of-Care.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
Upper limb functional electrical stimulation devices and their man-machine interfaces.
[Treatment of transplantation of NT-3 gene modified olfactory ensheathing cells on experimental autoimmune encephalomyelitis in rats].
Ginger Extract Reduces the Expression of IL-17 and IL-23 in the Sera and Central Nervous System of EAE Mice.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Characterizing cognitive function during relapse in multiple sclerosis.
Biomarkers in multiple sclerosis: an update for 2014.
The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.
Clinical profile and aetiology of optic neuritis in Hospital Universiti Sains Malaysia--5 years review.
Characterization of anti-natalizumab antibodies in multiple sclerosis patients.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.
[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
Symptomatic Sinus Bradycardia After a Treatment Course Of High-dose Oral Prednisone.
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Pages
« first
‹ previous
…
388
389
390
391
392
393
394
395
396
…
next ›
last »